EUVIMEDEUVIMED entdecken
Fallbericht

Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in Addition to Tacrolimus and Everolimus: A Case Report

Azusa Kobayashi, Asami Takeda, Shoji Saito, Hibiki Shinjo, Daiki Iguchi, Kenta Futamura, Manabu Okada, Takahisa Hiramitsu, Shunji Narumi, Yoshihiko Watarai

Nephron · 2025

DOI: 10.1159/000546925 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephron, 2025. Verfasst von Azusa Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan, akobayashi@nagoya2.jrc.or.jp. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Kidney Transplantation, Valproic Acid, Everolimus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thrombotic microangiopathy (TMA) is a known complication in renal transplant recipients and is often associated with drugs like calcineurin inhibitors (CNIs) and mammalian target of rapamycin (mTOR) inhibitors. Additionally, toxic levels of valproic acid have been implicated in systemic TMA. This report describes a case of pathologic TMA in a renal allograft that may be induced by the combined use of CNI, mTOR inhibitor, and valproic acid at standard doses. Case Presentation: A 37-year-old female diagnosed with glomerulonephritis underwent ABO-compatible living donor renal transplantation. Following the procedure, the blood concentrations of tacrolimus (CNI) and everolimus (mTOR inhibitor) were maintained at optimal levels. Two and a half years posttransplant, valproic acid therapy was initiated for migraine management and titrated within the therapeutic range. Despite the gradual decline in renal function, there was no evidence of anemia or thrombocytopenia. Four years posttransplant, a graft biopsy identified a necrotic thrombotic microvascular lesion suggestive of acute TMA, despite no signs of rejection. Renal function stabilized after the discontinuation of valproic acid.

Conclusion

Pathological TMA may impair renal function in patients receiving multiple drugs known to induce TMA. Hence, an early graft biopsy may be crucial for diagnosis, even when blood levels of immunosuppressive drugs are within the therapeutic range.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombotic MicroangiopathiesKidney TransplantationValproic AcidEverolimusTacrolimusImmunosuppressive AgentsHumansFemaleAdultAllografts

Stichwörter der Autor:innen

Allograft kidneyCase reportThrombotic microangiopathyValproic acid

Substanzen

Valproic AcidEverolimusTacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Nephrology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan, akobayashi@nagoya2.jrc.or.jp.
  • Nephrology, Masuko Memorial Hospital, Nagoya, Japan.
  • Nephrology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Transplant Nephrology and Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.

Zitieren

APA

Kobayashi, A., Takeda, A., Saito, S., Shinjo, H., Iguchi, D., Futamura, K., Okada, M., Hiramitsu, T., Narumi, S., & Watarai, Y. (2025). Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in Addition to Tacrolimus and Everolimus: A Case Report. Nephron. https://doi.org/10.1159/000546925

Vancouver

Kobayashi A, Takeda A, Saito S, Shinjo H, Iguchi D, Futamura K, et al. Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in Addition to Tacrolimus and Everolimus: A Case Report. Nephron. 2025. doi:10.1159/000546925

BibTeX
@article{Kobayashi2025,
  author = {Kobayashi, Azusa and Takeda, Asami and Saito, Shoji and Shinjo, Hibiki and Iguchi, Daiki and Futamura, Kenta and Okada, Manabu and Hiramitsu, Takahisa and Narumi, Shunji and Watarai, Yoshihiko},
  title = {Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in Addition to Tacrolimus and Everolimus: A Case Report},
  journal = {Nephron},
  year = {2025},
  doi = {10.1159/000546925}
}
Kostenlos starten →